A "Pending patent application" published at the USPTO today:
http://appft1.uspto.gov/netacgi/nph-Parser...0506+AND+ACN/au)
United States Patent Application..20100113337
Kind Code A1
Wolgen; Philippe
May 6, 2010
METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS
Abstract
A method for treatment to reduce the incidence or rate of development of skin cancers and related conditions caused by or exacerbated by or associated with UVR-induced skin damage in an immuno-compromised subject, such as an organ transplant patient, comprises the step of administering to said subject an amount of an alpha-MSH analogue effective to protect the skin of the subject from UVR-induced skin damage.
Inventors:Wolgen; Philippe; (Melbourne, AU)
Correspondence Name and Address:
POLSINELLI SHUGHART PC 700 W. 47TH STREET, SUITE 1000 KANSAS CITY MO 64112-1802 US
Assignee Name and Address:
Clinuvel Pharmaceuticals Limited Melbourne (AU)
from the uspto today
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $664.8M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |